Abstract
Background/Aim. Contrast-induced acute kidney injury (CI-AKI) is a common complication after the percutaneous coronary intervention, associated with a prolonged hospital stay, increased medical costs, and risk of adverse clinical outcomes. The aim of this study was to compare changes in levels of serum creatinine (sCr) and cystatin C (sCyC) 24 h after coronary angiography as an early indicator of CI-AKI. Methods. The study included 45 patients with chronic renal failure grade I–III scheduled for coronary angiography. Levels of sCr and sCyC were measured a day before and 24 h after coronary angiography. CI-AKI was defined as a 25% and 10% increase of sCr and sCyC levels from baseline within 24 h from contrast media exposure, in the absence of alternative causes. Results. Mean sCr and sCyC concentrations were 86.4 ± 22.6 µmol/L and 1.18 ± 0.52 mg/dL, respectively before contrast administration, and 90.6 ± 24.1 µmol/L and 1.24 ± 0.65 mg/dL, respectively 24 h after contrast media exposure. sCr-based CI-AKI occurred in 4 patients (8.89%) and sCyC-based CI-AKI was detected in 19 patients (42.22%) after the contrast procedure (p < 0.001). Conclusion. sCyC level measured 24 h after contrast media exposure is a more sensitive indicator of CI-AKI than sCR level.
Keywords
kidney failure, chronic
coronary angiography
creatinine
cystatin c
References
Aubry P, Brillet G, Catella L, Schmidt A, Bénard S. Outcomes, risk factors and health burden of contrast-induced acute kid-ney injury: an observational study of one million hospitaliza-tions with image-guided cardiovascular procedures. BMC Nephrol 2016; 17: 167.
Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 2014; 7(1): 1–9.
Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficien-cy. Am J Kidney Dis 2002; 39(5): 930‒6.
Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast Media Safety Committee of Euro-pean Society of Urogenital Radiology (ESUR) Contrast in-duced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21(12): 2527–41.
Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. In-cidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 2014; 9(1): 12–20.
Kellum JA, Lameire, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: Improving global out-comes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kindey Int Suppl 2012; 2(1): 1‒138.
Solomon R, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al. The CARE (Cardiac Angiography in Renally Impaired Patients) Study: A randomized, double-blind trial of contrast-induced nephropathy in high risk patients. Circula-tion 2007; 115(25): 3189‒96.
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, et al. Nephrotoxic effects in highrisk patients undergoing angiography. N Engl J Med 2003; 348(6): 491‒9.
Morcos SK, Thomsen HS. European Society of Urogenital Radi-ology. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28(2): 187–90.
McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103(5): 368‒75.
Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic con-trast media in 1196 patients: a randomized trial: the Iohexol Cooperative Study. Kidney Int 1995; 47(1): 254‒61.
Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: Physiological principles. Intensive Care Med 2004; 30(1): 33‒7.
American Society of Nephrology. American Society of Nephrology Renal Research Report. J Am Soc Nephrol 2005; 16(7): 1886‒903.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 Aug; 8(4): R204-12.
Wasung ME, Chawla LS, Madero M. Biomarkers of renal func-tion, which and when? Clin Chim Acta 2015; 438: 350–7.
Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921‒6.
Onopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C: a kidney function biomarker. Adv Clin Chem 2015; 68: 57–69.
Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, et al. Cystatin C and contrast-induced acute kidney injury. Circulation 2010; 121(19): 2117–22.
Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, et al. Time course of serial cystatin C levels in com-parison with serum creatinine after application of radiocon-trast media. Clin Nephrol 2004; 61(2): 98‒102.
Ribichini F, Gambaro G, Graziani MS, Pighi M, Pesarini G, Pasoli P, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem 2012; 58(2): 458–64.
Xu Q, Wang N, Duan S, Liu N, Lei R, Cheng W, Zhou SK. Se-rum cystatin c is not superior to serum creatinine for early di-agnosis of contrast-induced nephropathy in patients who un-derwent angiography. J Clin Lab Anal 2017; 31(5): doi: 10.1002/jcla.22096.
National Kidney Foundation. K/DOQI clinical practice guide-lines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1‒266.
Kim GS, Ko YG, Shin DH, Kim JS, Kim BK, Choi D, et al. Ele-vated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in pa-tients with peripheral artery disease undergoing endovascular therapy. J Vasc Surg 2015; 61(5): 1223‒30.
Dalton RN. Serum creatinine and glomerular filtration rate: Perception and reality. Clin Chem 2010; 56(5): 687‒9.
Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR – history, indica-tion and future research. Clin Biochem 2005; 38: 1‒8.
Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, et al. Association between increases in urinary neutrophil gelati-nase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; 105(3): 485‒91.
Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, et al. Time course of serial cystatin C levels in com-parison with serum creatinine after application of radiocon-trast media. Clin Nephrol 2004; 61(2): 98‒102.
Bellomo R. Decade in review – acute kidney injury: acute kid-ney injury - a decade of progress. Nat Rev Nephrol 2015; 11(11): 636–7.
Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, et al. Ef-fect of N-acetylcysteine on cystatin C-based renal function af-ter elective coronary angiography (ENABLE Study): a pro-spective, randomized trial. Int J Cardiol 2010; 138(3): 239–45.
Feng Y, Zhang Y, Li G, Wang L. Relationship of cystatin-C change and the prevalence of death or dialysis need after acute kidney injury: a meta-analysis. Nephrology (Carlton) 2014; 19(11): 679–84.
Yin L, Li G, Liu T, Yuan R, Zheng X, Xu G, Xu Y et al. Probucol for the prevention of cystatin C-based contrast-induced acute kidney injury following primary or urgent angi-oplasty: a randomized, controlled trial. Int J Cardiol 2013; 167(2): 426–9.
Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, et al. Cystatin C and contrast-induced acute kidney injury. Circulation 2010; 121(19): 2117‒22.
Zhang WF, Zhang T, Ding D, Sun SQ, Wang XL, Chu SC, et al. Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast-Induced Acute Kidney Injury and Its Clinical Implications. J Am Heart Assoc 2017; 6(1): pii: e004747.
Liu XL, Wang ZJ, Yang Q, Yu M, Shen H, Nie B, et al. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention. Chin Med J (Engl) 2012; 125(6): 1051‒6.
Ribichini F, Gambaro G, Graziani MS, Pighi M, Peasrini G, Paso-li P, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem 2012; 58(2): 458‒64.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105(19): 2259‒64.
Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of con-trast-induced nephropathy after percutaneous coronary inter-vention. J Invasive Cardiol 2003; 15(1): 18‒22.
Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, et al. Cardiovascular and renal toxicity of a nonionic radi-ographic contrast agent after cardiac catheterization: a pro-spective trial. Ann Intern Med 1989; 110(2): 119‒24.
Hall KA, Wong RW, Hunter GC, Camazine BM, Rappaport WA, Smyth SH, et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. J Surg Res 1992; 53(4): 317‒20.
Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, et al. The prognostic implications of further renal func-tion deterioration within 48 h of interventional coronary pro-cedures in patients with pre-existent chronic renal insufficien-cy. J Am Coll Cardiol 2000; 36(5): 1542‒8.
Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79(2): 211‒9.
Zhang T, Shen LH, Hu LH, He B. Statins for the prevention of contrast‐induced nephropathy: a systematic review and me-ta‐analysis. Am J Nephrol 2011; 33(4): 344–51.
Gupta R, Moza A, Cooper CJ. Intravenous hydration and con-trast‐induced acute kidney injury: too much of a good thing? J Am Heart Assoc 2016; 5(6). pii: e003777.